Evaluating the Risk of Serious Ventricular Arrhythmia and Sudden Cardiac Death Among Users of Domperidone
NCT ID: NCT00925457
Last Updated: 2016-07-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1608 participants
OBSERVATIONAL
2007-03-31
2009-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Drug-Induced Sudden Death & Ventricular Arrhythmia
NCT00102180
Antiarrythmic Drugs - Long-term Follow-up in the Modern Era
NCT01082055
NORDIC: Nitric Oxide-Derived Oxidants and Regional Endothelial and Diastolic Dysfunction in Dilated Cardiomyopathy
NCT00293137
Medications and the Risk of Sudden Cardiac Death
NCT00241800
Efficacy and Safety of Sulcardine Sulfate Tablets in Patients With Premature Ventricular Contractions
NCT01235156
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
001
Current Domperidone Current domperidone at any dose regardless of proton pump inhibitor status
Current Domperidone
Current domperidone at any dose, regardless of proton pump inhibitor status
002
Current proton pump inhibitor (PPI) Current PPI and not current dapoxetine
Current proton pump inhibitor (PPI)
Current PPI and not current dapoxetine
003
No Intervention Neither current domperidone nor current PPI
No Intervention
Neither current domperidone nor current PPI
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No Intervention
Neither current domperidone nor current PPI
Current Domperidone
Current domperidone at any dose, regardless of proton pump inhibitor status
Current proton pump inhibitor (PPI)
Current PPI and not current dapoxetine
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
99 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Johnson & Johnson Pharmaceutical Research & Development, L.L. C. Clinical Trial
Role: STUDY_DIRECTOR
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Related Links
Access external resources that provide additional context or updates about the study.
Evaluating the Risk of Serious Ventricular Arrhythmia and Sudden Cardiac Death Among Users of Domperidone
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CR016396
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.